Edmund Harrigan, Director at PhaseBio Pharmaceuticals Inc (PHAS), bought 6,000 shares at $4.12 ($25K) on 2020-12-03, disclosed to the SEC on 2020-12-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KRTX | SELL | 2020-06-15 | $2.8M | — | Filing → |
| ACAD | BUY | 2016-08-18 | $33K | — | Filing → |